medRxiv (Cold Spring Harbor Laboratory),
Год журнала:
2024,
Номер
unknown
Опубликована: Март 9, 2024
Abstract
Background
Recurrent
infections
of
the
nose,
sinuses,
and
ears
are
common
problems
for
people
with
primary
ciliary
dyskinesia
(PCD).
While
pulmonary
exacerbations
in
PCD
defined,
there
is
no
definition
Ear-Nose-Throat
(ENT)
exacerbations,
a
potential
outcome
research
clinical
trials.
Methods
We
set
up
an
expert
panel
24
ENT
specialists,
respiratory
physicians,
other
healthcare
professionals,
patients
to
develop
consensus
definitions
sinonasal
otologic
children
adults
settings.
reviewed
literature
used
modified
Delphi
approach
four
electronic
surveys.
Results
Both
based
on
combination
major
minor
criteria,
requiring
three
or
two
at
least
criteria
each.
Major
exacerbation
are:
1)
reported
acute
increase
nasal
discharge
change
colour;
2)
pain
sensitivity
sinus
regions;
3)
mucopurulent
examination.
Minor
include:
symptoms;
examination
signs;
doctoŕs
decision
treat;
improvement
after
14-days.
ear
sensitivity,
discharge,
examination,
4)
signs
otitis
media
otoscopy.
hearing
problems;
complication;
treat.
Conclusion
These
might
offer
useful
measure
different
They
should
be
validated
future
studies
trials
together
outcomes,
assess
their
usability.
Trends in Microbiology,
Год журнала:
2025,
Номер
unknown
Опубликована: Янв. 1, 2025
Within
both
abiotic
and
host
environments,
bacteria
typically
exist
as
diverse,
multispecies
communities
have
crucial
roles
in
human
health,
agriculture,
industry.
In
these
communities,
compete
for
resources,
competitive
interactions
can
shape
the
overall
population
structure
community
function.
Studying
bacterial
dynamics
requires
experimental
model
systems
that
capture
different
interaction
networks
between
their
surroundings.
We
examine
recent
literature
advancing
such
systems,
including
(i)
silico
models
establishing
theoretical
basis
how
cell-to-cell
influence
level
dynamics,
(ii)
vitro
characterizing
specific
interbacterial
interactions,
(iii)
organ-on-a-chip
revealing
physiologically
relevant
parameters,
spatial
mechanical
forces,
encounter
within
a
host,
(iv)
vivo
plant
animal
connecting
responses
to
interactions.
Each
of
has
greatly
contributed
our
understanding
be
used
synergistically
understand
competition
influences
architecture.
npj Biofilms and Microbiomes,
Год журнала:
2022,
Номер
8(1)
Опубликована: Окт. 18, 2022
Abstract
Experimental
evolution
experiments
in
which
bacterial
populations
are
repeatedly
exposed
to
an
antimicrobial
treatment,
and
examination
of
the
genotype
phenotype
resulting
evolved
bacteria,
can
help
shed
light
on
mechanisms
behind
reduced
susceptibility.
In
this
review
we
present
overview
why
it
is
important
include
biofilms
experimental
evolution,
approaches
available
study
what
has
taught
us
about
tolerance
resistance
biofilms.
Finally,
emerging
consensus
view
biofilm
susceptibility
supported
by
data
obtained
during
studies.
FEMS Microbiology Reviews,
Год журнала:
2022,
Номер
46(5)
Опубликована: Апрель 24, 2022
Pseudomonas
aeruginosa
is
a
human
pathogen
associated
with
both
acute
and
chronic
infections.
While
intensively
studied,
the
basic
mechanisms
enabling
long-term
survival
of
P.
in
host,
despite
massive
immune
system
attack
heavy
antimicrobial
treatment,
remain
to
be
identified.
We
argue
that
such
infections
may
represent
niche
invasions
by
influence
microenvironment
depleting
host-derived
substrate
activating
response.
Bacteria
embedded
cell
aggregates
establish
microenvironmental
niche,
where
they
endure
initial
host
response
slowing
down
their
metabolism.
This
provides
stable,
lasting
growth
conditions
constant,
albeit
slow
supply
electron
acceptors.
Under
stable
conditions,
exhibits
distinct
adaptive
traits,
its
gene
expression
pattern
reflects
life
exposed
continuous
antimicrobials.
Here,
we
review
fundamental
aspects
examine
how
structural
organization
influences
vivo
microenvironment,
which
turn
affects
interaction
biofilm
system.
discuss
improving
our
knowledge
about
ecology
can
used
combat
persistent,
hard-to-treat
bacterial
PLoS Biology,
Год журнала:
2024,
Номер
22(4), С. e3002566 - e3002566
Опубликована: Апрель 23, 2024
Phage
therapy
is
a
therapeutic
approach
to
treat
multidrug-resistant
(MDR)
infections
that
employs
lytic
bacteriophages
(phages)
eliminate
bacteria.
Despite
the
abundant
evidence
for
its
success
as
an
antimicrobial
in
Eastern
Europe,
there
scarce
data
regarding
effects
on
human
host.
Here,
we
aimed
understand
how
phages
interact
with
cells
of
airway
epithelium,
tissue
site
colonized
by
bacterial
biofilms
numerous
chronic
respiratory
disorders.
Using
panel
Pseudomonas
aeruginosa
and
epithelial
(AECs)
derived
from
person
cystic
fibrosis
(CF),
determined
interactions
between
depend
specific
phage
properties
well
physiochemical
features
microenvironment.
Although
poor
at
internalizing
phages,
epithelium
responds
exposure
changing
transcriptional
profile
secreting
antiviral
proinflammatory
cytokines
correlate
families.
Overall,
our
findings
indicate
mammalian
responses
are
heterogenous
could
potentially
alter
way
local
defenses
aid
clearance
during
therapy.
Thus,
besides
receptor
specificity
particular
isolate,
criteria
select
should
be
expanded
include
cell
responses.
Cell Reports,
Год журнала:
2023,
Номер
42(3), С. 112270 - 112270
Опубликована: Март 1, 2023
The
cystic
fibrosis
(CF)
respiratory
tract
harbors
pathogenic
bacteria
that
cause
life-threatening
chronic
infections.
Of
these,
Pseudomonas
aeruginosa
becomes
increasingly
dominant
with
age
and
is
associated
worsening
lung
function
declining
microbial
diversity.
We
aimed
to
understand
why
P.
dominates
over
other
pathogens
disease.
Here,
we
show
responds
dynamic
changes
in
iron
concentration,
often
viral
infection
pulmonary
exacerbations,
become
more
competitive
via
expression
of
the
TseT
toxic
effector.
However,
this
behavior
can
be
therapeutically
targeted
using
chelator
deferiprone
block
competition.
Overall,
find
concentration
significantly
correlate
diversity
people
CF.
These
findings
improve
our
understanding
how
CF
provide
a
targetable
pathway
help
prevent
shift.
Microbiology Spectrum,
Год журнала:
2024,
Номер
12(8)
Опубликована: Июнь 25, 2024
ABSTRACT
Elexacaftor/tezacaftor/ivacaftor
(ETI)
therapy
has
revolutionized
the
treatment
of
cystic
fibrosis
(CF)
for
most
affected
individuals
but
effects
on
sinus
microbiota
are
still
unknown.
Changes
to
airway
in
CF
associated
with
disease
state
and
alterations
bacterial
community
after
ETI
initiation
may
require
changes
clinical
management
regimens.
We
collected
swab
samples
from
middle
meatus
an
observational
study
38
adults
chronic
rhinosinusitis
(CRS)
2017
2021
captured
therapy.
performed
16S
custom
amplicon
sequencing
characterize
pre-
post-ETI.
Real-time
quantitative
PCR
(RT-qPCR)
was
estimate
total
abundance.
Sinus
people
(pwCF)
clustered
into
three
types,
dependent
dominant
organism:
a
Pseudomonas
-dominant,
Staphylococcus
mixed
dominance
cluster.
Shannon’s
diversity
index
low
not
significantly
altered
Total
load
lowered
spp.
abundance
reduced
post-ETI,
eradication
observed.
became
organism
post-ETI
we
showed
presence
methicillin-resistant
aureus
(MRSA)
both
also
demonstrated
that
microbiome
is
predictive
spp.,
Serratia
sputum.
including
MRSA,
persist
sinuses
pwCF
therapy,
indicating
these
pathogens
will
continue
be
important
era
highly
effective
modulator
therapies
(HEMT).
IMPORTANCE
Highly
(HEMT),
such
as
elexacaftor/tezacaftor/ivacaftor
(ETI),
have
patient
care
quality
life
individuals.
The
airways
unclear,
though
work
already
been
published
Our
presents
evidence
relative
following
show
becomes
communities
this
cohort
identified
post-therapy.
These
findings
demonstrate
pathogen
monitoring
remain
vital
part
HEMT.
PLoS Biology,
Год журнала:
2024,
Номер
22(8), С. e3002781 - e3002781
Опубликована: Авг. 23, 2024
Metabolism
provides
the
foundation
for
all
cellular
functions.
During
persistent
infections,
in
adapted
pathogenic
bacteria
metabolism
functions
radically
differently
compared
with
more
naïve
strains.
Whether
this
is
simply
a
necessary
accommodation
to
persistence
phenotype
or
if
plays
direct
role
achieving
host
still
unclear.
Here,
we
characterize
convergent
shift
metabolic
function(s)
linked
during
Pseudomonas
aeruginosa
colonization
airways
of
people
cystic
fibrosis.
We
show
that
clinically
relevant
mutations
key
enzyme,
pyruvate
dehydrogenase,
lead
host-specialized
together
lower
virulence
and
immune
response
recruitment.
These
changes
infection
are
mediated
by
impaired
type
III
secretion
system
activity
antioxidant
metabolite,
pyruvate,
respectively.
Our
results
how
adaptations
directly
impinge
on
pathogenicity
organism.
International Forum of Allergy & Rhinology,
Год журнала:
2025,
Номер
unknown
Опубликована: Март 2, 2025
ABSTRACT
Background
Severe
chronic
rhinosinusitis
(CRS)
is
a
near
universal
manifestation
of
cystic
fibrosis.
Elexacaftor/tezacaftor/ivacaftor
(ETI)
an
oral,
small
molecule,
highly
effective
Cystic
Fibrosis
Transmembrane
Conductance
Regulator
(CFTR)
corrector–potentiator
drug.
In
people
with
fibrosis
age
>
12
years,
ETI
improves
sinonasal
symptoms,
endoscopy
findings,
polyp
size,
and
radiologic
findings.
This
study
evaluates
changes
in
CRS
children
ages
6–12
years
newly
started
on
ETI.
Methods
was
prospective,
three
center,
pre–post
11
6–11
Study
endpoints
included
the
SN‐5
health
survey,
Sniffin’
Kids
olfaction
test,
sinus
computerized
tomography
(CT)
scan,
nasal
mucus
sampling
for
full‐length
16S
rRNA
sequencing
microbiome
analysis.
visits
were
conducted
before
at
median
9
months
after
treatment
initiation.
Results
lead
to
improvement
scores
findings
CRS.
Olfaction
below
normal
baseline
did
not
improve.
The
dominated
by
typically
commensal
organisms
most
participants.
Additionally,
Staphylococcus
aureus
found
five
participants
six
treatment.
Conclusions
symptoms
age.
improve
this
group,
suggesting
that
olfactory
dysfunction
associated
CF
established
early
life.
younger
cohort
pediatric
patients
presented
abundant
only
very
rare
Pseudomonas
aeruginosa
or